PMC · DOI:10.1093/jncics/pkaf092·October 26, 2025
Leveraging real-world evidence to personalize adjuvant therapy in HR+/HER2- early breast cancer
Yael Bar, Steven J Isakoff, Seth A Wander
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHER2/EGFR in Cancer Research · Advanced Breast Cancer Therapies · Breast Cancer Treatment Studies